NCT05661799

Brief Summary

Many programmes exist to enable patients to engage in physical activity, but it is clear that the objectives are often not achieved in terms of quality, quantity or intensity of practice. In this study, the aim is to find alternatives, assuming that strengthening patients' self-efficacy, meeting their basic needs and increasing their level of hope will have an impact on their motivation to practice, which in turn will have an impact on their actual practice. The aim is to develop and implement an innovative intervention programme and to identify the interactions between the variables that are assumed to predict engagement in practice.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
77

participants targeted

Target at P25-P50 for not_applicable diabetes-mellitus-type-2

Timeline
Completed

Started Sep 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 9, 2021

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

November 9, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 22, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2023

Completed
Last Updated

December 22, 2022

Status Verified

December 1, 2022

Enrollment Period

1.6 years

First QC Date

November 9, 2022

Last Update Submit

December 21, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Change in amount of physical activity assessed by the French Version of GPAQ

    The evolution of the quantity of physical activity will be the main criterion of judgment. It will be measured by the Global Physical Activity Questionnaire, which will allow for differentiation of intensities and contexts of practice. This questionnaire will be administered at each evaluation time proposed by the study (before/after, at 3, 6 and 12 months). The higher the score (in Metabolic Equivalent of Task/minutes/weeks), the greater the amount and intensity of physical activity performed. The comparison between the pre- and post-programme assessments (e.g. T0 and T1) will allow the direct effect of the programme on the amount of physical activity to be determined. The other assessments (e.g. T2, T3 and T4) will determine the persistence of this practice over time.

    Pre-intervention/immediately after the intervention, at 3, 6 and 12 months after the intervention

Secondary Outcomes (12)

  • Change in the subjects' motivational profile towards a more self-determined motivation assessed by the French Version of the Motivation for Physical Activity for Health Scale

    Pre-intervention/immediately after the intervention, at 3, 6 and 12 months after the intervention

  • Change in the satisfaction of basic psychological needs assessed by the French Version of The Basic Psychological Needs.

    Pre-intervention/immediately after the intervention, at 3, 6 and 12 months after the intervention

  • Change in self-efficacy assessed by the French Version of The Self-Efficacy Questionnaire

    Pre-intervention/immediately after the intervention, at 3, 6 and 12 months after the intervention

  • Change of initial state hope level assessed by the French Version of the State Hope Scale

    Pre-intervention/immediately after the intervention, at 3, 6 and 12 months after the intervention

  • Change in dispositional hope level assessed by the French Version of the Adult Dispositional Hope Scale

    Pre-intervention/immediately after the intervention

  • +7 more secondary outcomes

Study Arms (2)

Intervention Group

EXPERIMENTAL

The proposed intervention consists of one hour of adapted physical activity per week for 12 weeks, led by a professional. In addition to this intervention, the intervention includes two 15-minute sessions, one before and one after the session. At the end of each session, a PA challenge and a positive reinforcement exercise will be proposed. The participants will have a week to try to achieve these. In addition to these two 15-minute sessions, participants will benefit from a one-and-a-half hour group session for information and experience sharing. The aim of this session is to discuss different topics related to diabetes.

Behavioral: Intervention Group

Control group

ACTIVE COMPARATOR

The proposed intervention consists of one hour of adapted physical activity per week for 12 weeks, led by a professional.

Behavioral: Control Group

Interventions

The programme is a PA programme consisting of one weekly session for 12 weeks. The one hour of PA is supplemented by two 15-minute periods. At the end of each session, a PA challenge and a positive reinforcement exercise are proposed for the coming week. At the beginning of the next session, the facilitator has a dedicated time to give feedback on these challenges (successes and difficulties encountered). At the end of each session, the facilitator explains the theme of the next challenge and exercise. For the challenge, three options are proposed. Each participant chooses the option he/she prefers. Positive reinforcement exercises are also offered in the same way. They aim to strengthen motivation, hope and the sense of self-efficacy (SEP). In addition to these two 15-minute sessions, participants are offered a one-and-a-half hour group session for information and experience sharing. The aim of this session is to discuss different themes.

Intervention Group
Control GroupBEHAVIORAL

The programme is a PA programme consisting of one weekly session for 12 weeks.

Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject over 18 years of age
  • Subject who has given signed consent to participate in the protocol
  • Type 2 diabetic subject not treated with insulin
  • Subject participating for the first time in adapted physical activity sessions provided by Siel Bleu
  • Subject understanding and reading French

You may not qualify if:

  • Subjects with major health problems that prevent them from continuing the programme.
  • Subjects who have withdrawn their consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Elise Maudet-Coulomb

Angers, Maine Et Loire, 49000, France

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2Motor Activity

Interventions

Control Groups

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesBehavior

Intervention Hierarchy (Ancestors)

Epidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Elise Maudet-Coulomb, Ms

    Université de Lorraine, EA 4360 APEMAC, Metz, France

    PRINCIPAL INVESTIGATOR
  • Charles Martin-Krumm, PhD

    Université de Lorraine, EA 4360 APEMAC, Metz, France

    STUDY CHAIR
  • Jean-Christophe Mino, PhD

    Institut de recherche Siel Bleu, Paris France

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 9, 2022

First Posted

December 22, 2022

Study Start

September 9, 2021

Primary Completion

April 1, 2023

Study Completion

April 1, 2023

Last Updated

December 22, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations